Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)

KRW 10440.0

(-2.61%)

Market Cap (In KRW)

239.74 Billion

Revenue (In KRW)

13.72 Million

Net Income (In KRW)

-10.27 Billion

Avg. Volume

225.39 Thousand

Currency
KRW
Country
Open
-
Prev. Close
-
Day Range
-
Year Range
10360.0-25200.0
PE
-
EPS
-
Beta Value
3.721
ISIN
KR7323990002
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Industry
CEO
-
Employee Count
-
Website
https://www.vaxcell-bio.com
Ipo Date
2020-09-22
Details
Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea.